It is worth noting that immune exclusion, which causes resistance to ICB, can result in a different metabolic tumor microenvironment due to reduced levels of infiltrating CD8+ T cells and IFNγ gene signature, which also impact the outcome of metabolic innervation. The gene discussed is IFNG; the disease is neoplasm.